Loading data
BCDANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 4.96 m USD | 4.39 m USD | 7.73 m USD | 8.83 m USD | 8.56 m USD |
| Selling, general and administrative expense | 3.32 m USD | 3.67 m USD | 4.4 m USD | 4.42 m USD | 5.09 m USD |
| Operating profit | -8.28 m USD | -8 m USD | -11.64 m USD | -11.9 m USD | -12.63 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -8.23 m USD | -7.95 m USD | 11.57 m USD | 11.91 m USD | -12.62 m USD |
| Basic earnings per share | -1.23 USD/share | -2.9 USD/share | -8.19 USD/share | -0.67 USD/share | -0.75 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.